Wilms' tumor and preferentially expressed antigen of melanoma in patients with myeloid neoplasms treated with azacytidine
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Haematology"
DOI: 10.1111/ejh.13312
Abstract: In their recent paper, Santaliestra et al measured bone marrow (BM) Wilms' tumor (WT1) mRNA levels in patients with myeloid neoplasms treated with 5-azacytidine (5-AZA)1 . Patients with initial WT1 levels greater than 100 copies but… read more here.
Keywords: myeloid neoplasms; tumor preferentially; neoplasms treated; treated azacytidine ... See more keywords
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase‐targeted therapy
Sign Up to like & getrecommendations! Published in 2022 at "Histopathology"
DOI: 10.1111/his.14680
Abstract: Recurrent alterations involving receptor tyrosine or cytoplasmic kinase genes have been described in soft‐tissue neoplasms such as infantile fibrosarcoma (IFS) and inflammatory myofibroblastic tumour (IMT). Recent trials and regulatory approvals for targeted inhibitors against the… read more here.
Keywords: mesenchymal neoplasms; characterization paediatric; neoplasms treated; histologic characterization ... See more keywords